The advancement in therapy has provided a dramatic improvement in the rate of recovery
among cancer patients. However, this improved survival is also associated with enhanced …

Recent therapeutic advances have significantly improved the short‐and long‐term survival
rates in patients with heart disease and cancer. Survival in cancer patients may, however, be …

Chemotherapy and targeted therapies have significantly improved the prognosis of
oncology patients. However, these antineoplastic treatments may also induce adverse …

Drug-induced cardiotoxicity is emerging as an important issue among cancer survivors. For
several decades, this topic was almost exclusively associated with anthracyclines, for which …

As medicine advances to employ sophisticated anticancer agents to treat a vast array of
oncological conditions, it is worth considering side effects associated with several …

In recent years, the development of more effective drugs has provided a better prognosis
and an increase in life expectancy for patients at all-stages of cancer. On the other hand, the …

Tremendous strides have been made in the treatment of various oncological diseases such
that patients are surviving longer and are having better quality of life. However, the success …

Although outcomes in cancer patients have dramatically improved with the development of
novel cancer chemotherapies and combination treatment, these developments are …

As the number of cancer survivors has increased significantly over the last decades due to
aging of population and development of effective cancer therapies, side effects from cancer …

The evolution of cancer treatment and development of new classes of anticancer therapies
have continued to revolutionize the field of oncology. New therapies including targeted …